The Soluble Interleukin‐6 Receptor a

[1]  S. Rose-John,et al.  Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells , 1994, The Journal of experimental medicine.

[2]  S. Rose-John,et al.  Identification of two novel regions of human IL-6 responsible for receptor binding and signal transduction. , 1994, Journal of immunology.

[3]  P. Heinrich,et al.  Soluble receptors for cytokines and growth factors: generation and biological function. , 1994, The Biochemical journal.

[4]  P. Heinrich,et al.  The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. , 1994, Journal of immunology.

[5]  G. Ciliberto,et al.  Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors. , 1994, The Journal of biological chemistry.

[6]  G. Ciliberto,et al.  Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion. , 1994, The EMBO journal.

[7]  G. Ciliberto,et al.  Generation of interleukin‐6 receptor antagonists by molecular‐modeling guided mutagenesis of residues important for gp130 activation. , 1994, The EMBO journal.

[8]  S. Ziegler,et al.  Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Akira,et al.  Cytokine signal transduction , 1994, Cell.

[10]  P. Heinrich,et al.  Development of a human interleukin-6 receptor antagonist. , 1994, The Journal of biological chemistry.

[11]  D. Friend,et al.  Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor receptor and gp130 cooperate in signal transduction in hepatic and neuronal cells , 1994, Molecular and cellular biology.

[12]  N. Udagawa,et al.  Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Heinrich,et al.  Intracellular retention of interleukin-6 abrogates signaling. , 1993, The Journal of biological chemistry.

[14]  P. Heinrich,et al.  Differential shedding of the two subunits of the interleukin‐6 receptor , 1993, FEBS letters.

[15]  G. Yancopoulos,et al.  The alphas, betas, and kinases of cytokine receptor complexes , 1993, Cell.

[16]  G. Yancopoulos,et al.  Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. , 1993, Blood.

[17]  P. Heinrich,et al.  Recombinant soluble human interleukin-6 receptor. Expression in Escherichia coli, renaturation and purification. , 1993, European journal of biochemistry.

[18]  P. Heinrich,et al.  Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules. Involvement of two separate domains in receptor binding. , 1993, The Journal of biological chemistry.

[19]  G. Yancopoulos,et al.  LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. , 1993, Science.

[20]  K. Yasukawa,et al.  IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. , 1993, Science.

[21]  D Eisenberg,et al.  The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Horowitz.  Cytokines and estrogen in bone: anti-osteoporotic effects. , 1993, Science.

[23]  P. Heinrich,et al.  The soluble interleukin‐6 receptor is generated by shedding , 1993, European journal of immunology.

[24]  P. Heinrich,et al.  Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor. , 1992, Biochemical and biophysical research communications.

[25]  L. D. Ward,et al.  A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Heinrich,et al.  Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. , 1992, Journal of immunology.

[27]  D. Fowlkes,et al.  Identification of a receptor binding site in the carboxyl terminus of human interleukin-6. , 1992, The Journal of biological chemistry.

[28]  K. Yasukawa,et al.  Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. , 1992, Journal of immunology.

[29]  Comeau,et al.  The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. , 1992, Science.

[30]  P. Heinrich,et al.  Up‐regulation of the interleukin‐6‐signal transducing protein (gp130) by interleukin‐6 and dexamethasone in HepG2 cells , 1992, FEBS letters.

[31]  T. Tedder.  Cell-surface receptor shedding: a means of regulating function. , 1991, American journal of respiratory cell and molecular biology.

[32]  T. Hirano,et al.  Structural and functional studies on the human hepatic interleukin-6 receptor. Molecular cloning and overexpression in HepG2 cells. , 1991, The Biochemical journal.

[33]  P. Heinrich,et al.  Evidence for the importance of a positive charge and an α‐helical structure of the C‐terminus for biological activity of human IL‐6 , 1991, FEBS letters.

[34]  T. Hirano,et al.  Molecular cloning and expression of an IL-6 signal transducer, gp130 , 1990, Cell.

[35]  P. Heinrich,et al.  The three carboxy‐terminal amino acids of human interleukin‐6 are essential for its biological activity , 1990, FEBS letters.

[36]  F. D. Di Padova,et al.  Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutants. , 1990, Journal of immunology.

[37]  T. Hirano,et al.  Studies on the structure and regulation of the human hepatic interleukin-6 receptor. , 1990, European journal of biochemistry.

[38]  T. Hirano,et al.  Structure‐function analysis of human interleukin‐6 , 1990, FEBS letters.

[39]  D. Wallach,et al.  Soluble cytokine receptors are present in normal human urine , 1989, The Journal of experimental medicine.

[40]  T. Hirano,et al.  Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 , 1989, Cell.

[41]  T. Taniguchi,et al.  Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. , 1988, Science.

[42]  S. Akira,et al.  Interleukin-6 in biology and medicine. , 1993, Advances in immunology.